Author

Thomas Harding

Institution: Clovis Oncology (United States)

Observed institution: Clovis Oncology (United States)

ORCID: 0009-0001-8674-3520

Observed ORCID: 0009-0001-8674-3520

OpenAlex ID: A5137173195

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al. · Clinical Cancer Research · 1

Supplementary Figure S5 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Supplementary Figure S2 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Supplementary Figure S1 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Supplementary Figure S6 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Supplementary Figure S3 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Supplementary Figure S4 from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Data from HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications

2026 · Kalyan Banda, Helen R. Davies, et al.

Works count: 8

Citation count: 1

H-index: 1

I10-index: